Latest Commercialisation News

Pearl Gull Iron Limited reported limited exploration during the March 2025 quarter due to seasonal weather, focusing on strategic planning and environmental compliance at its Cockatoo Island iron ore project. The company’s cash reserves declined to $185,000 amid ongoing care activities and exploration groundwork.

BluGlass Limited has achieved a world-record 1250mW single-mode GaN laser chip and strengthened its commercial pipeline with a $120,000 repeat order, positioning itself for rapid growth in photonics markets.

Conrad Asia Energy has secured a pivotal Gas Sales Agreement with Indonesia’s state utility PLN, linking Mako gas prices to the Indonesian Crude Price and advancing its farmout strategy while increasing its stake in the Duyung PSC to 91.5%.

Heavy Minerals Limited is on the cusp of releasing its Port Gregory Garnet Project Pre-Feasibility Study, while simultaneously exploring a promising new industrial minerals opportunity and advancing funding efforts.

Terragen Holdings has launched its new probiotic products for ruminants, initiated multiple key trials including methane mitigation and crop yield studies, and secured a US patent allowance, positioning itself for global market expansion.

Skin Elements Limited advances its natural biotechnology products with ECO-Nurture trials concluding and SuprCuvr disinfectant gaining traction, supported by a successful $656k capital raise.

Lithium Plus Minerals Limited (ASX: LPM) reported significant progress on its Lei Lithium Development with advancing environmental approvals and infrastructure design, while its Wingate Project reveals promising large-scale gold potential. The company maintains a solid cash position of AUD 3.6 million as it prepares for upcoming exploration campaigns.

Cadoux Limited has made significant progress in its High Purity Alumina and Minhub rare earth projects during Q1 2025, advancing engineering studies, securing key contracts, and strengthening ESG initiatives while preparing for commercialisation.

Renegade Exploration reports significant discoveries of critical defence metals germanium and gallium at its Yukon Andrew Deposit, alongside promising gold-silver prospects, while progressing copper and cobalt projects in Queensland amid a tight cash position.

Zenith Minerals reported a pivotal quarter advancing exploration at its Dulcie Far North and Red Mountain gold projects, while agreeing to divest its Turkish Kavaklitepe interest, sharpening its focus on domestic assets.

EVE Health Group has executed a binding agreement to acquire Australian biotech Nextract, targeting rapid-onset treatments in the $16 billion global erectile dysfunction and dysmenorrhea markets. The acquisition, supported by a $1.5 million capital raise and share consolidation, marks a strategic shift into regulated pharmaceutical channels.

FBR Limited wraps up its US Demonstration Program, secures $6.3 million in capital, and appoints Mark Pivac as CEO amid a 70% cost reduction drive. Strategic collaborations with Samsung Heavy Industries and Liebherr signal broader automation ambitions.